fashion -WSS

fashion

author：knowledge 2025-08-27 16:48:05 - browse：6

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Seattle police shoot person suspected in downtown stabbing

WSS

My chronic pain journey would have been easier knowing 5 things % STAT

Stanford updates investigation of president’s past research

Resistance to cancer drugs: A new genetic explanation

Couple fighting to bring baby home from Mexico are finally reunited

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Why some people catch Covid but never get sick

entertainment

fashion

focus

Activists slam private health insurers over coverage restrictions

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medical experts are missing from AI regulatory conversations

United colonoscopy coverage change 'may cost lives,' doctors say

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Hepatitis C has a cure — but many Americans still lack access to it

India sets sights on home

focus

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Statins reduce cardiovascular risk in people living with HIV

Ebola public health emergency is over, WHO declares

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

How to protect coverage of PrEP

Clinic falsely told dozens they had Alzheimer's, suits say

focus

entertainment

knowledge

Wikipedia